Skip to main content

Nonclinical Development of Biologics, Vaccines and Specialty Biologics

  • 2nd Edition - November 1, 2024
  • Editors: Lisa Plitnick, Claudette LaTonya Fuller
  • Language: English
  • Hardback ISBN:
    9 7 8 - 0 - 4 4 3 - 1 3 3 4 4 - 2
  • eBook ISBN:
    9 7 8 - 0 - 4 4 3 - 1 3 3 4 5 - 9

Nonclinical Development of Biologics, Biosimilars, Vaccines and Specialty Biologics, Second Edition is a complete reference devoted to the nonclinical safety assessment of novel… Read more

Nonclinical Development of Biologics, Vaccines and Specialty Biologics

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Book bundle cover eBook and print

Institutional subscription on ScienceDirect

Request a sales quote

Nonclinical Development of Biologics, Biosimilars, Vaccines and Specialty Biologics, Second Edition is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies, and blood products. Updated and revised, the new edition compares and contrasts these types of biologics with one another, and with small molecule drugs while incorporating the most current and essential international regulatory guidelines. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays.

This multi-edited book with chapters authored by leading qualified experts in the field offers a comprehensive reference on critical insights that will be of interest to researchers involved in early through late-stage biologics.